Tumors contain thousands of genetic changes, but only a few are actually cancer-causing. A quicker way to identify these driver mutations could lead to more targeted cancer treatments.

In a retrospective analysis, a team found that an algorithm integrating the gene expression of a tumor with the radiation dose a patient received predicted how well the patient responded to the treatment.

Researchers turned white blood cells called neutrophils into drug-smuggling “neutrobots,” which penetrated the blood-brain barrier to treat brain cancer in mice.

The cancer researcher and executive vice president of AstraZeneca’s oncology research and development is well known for his role in the development of pivotal breast cancer therapies.

The oncologist developed lifesaving childhood leukemia treatments and revolutionized chemotherapy.

The findings may have implications for radiotherapy, a cancer treatment that can cause damage to salivary glands and leave lasting complications.

Mice that experienced heart attacks underwent a large-scale shift in their immune systems that allowed cancer to flourish, perhaps explaining the observation in patients.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

Calls to include a new breast cancer subtype in future clinical trials reveal fundamental disagreements about HER2’s role in the disease.

The Vanderbilt University professor was awarded a Nobel Prize for his discovery of epidermal growth factor.

The radiation oncologist and chief medical executive at MD Anderson Cancer Center has not worked in government previously.

Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.

Meet researcher Elaine Mardis of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Ohio and coauthor of a feature article on cancer vaccines.